Outset Medical announced today that it partnered with U.S. Renal Care to accelerate home hemodialysis in the U.S. The company entered into a multi-year agreement with U.S. Renal Care, the country’s largest privately held kidney care provider. They aim to utilize the Outset Tablo hemodialysis system as a home dialysis option in the 33 states […]
Abbott increases guidance on strong Q1 results, reports progress on Volt PFA system
Abbott shares fell this today despite first-quarter results that came in ahead of the consensus forecast. Shares of ABT fell more than 3% to $105.81 apiece by later afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped slightly. The Abbott Park, Illinois-based medtech giant […]
Ypsomed, ten23 health collab on YpsoDose patch injector
Ypsomed announced today that it entered into a partnership with ten23 health to commercialize its YpsoDose wearable injector. Burgdorf, Switzerland-based Ypsomed designed YpsoDose for the subcutaneous self-injection of large-volume doses. ten23 health, a Swiss CDMO, offers drug development, filling and device assembly expertise to contribute to the product offering. The strategic collaboration sees both parties […]
CVRx has more data supporting long-term benefits of Barostim
CVRx (Nasdaq:CVRX) announced the publication of post-market data highlighting long-term, sustained benefits with its Barostim device. Minneapolis-based CVRx published results from the BeAT-HF trial in the European Journal of Heart Failure. Data supported Barostim treatment in heart failure patients with reduced ejection fraction. Barostim delivers electrical pulses to baroreceptors in the wall of the carotid […]
Cardiawave names new CEO
French non-invasive ultrasound therapy (NIUT) device developer Cardiawave announced today it appointed Olivier Pierron as its new CEO. Levallois-Perret, France-based Cardiawave develops its Valvosoft NIUT device for the treatment of severe symptomatic calcific aortic stenosis. As CEO, Pierron holds responsibility for overseeing the deployment of Valvosoft in the European market and U.S. clinical trials. He […]
FastWave Medical wins patent for laser-IVL tech
FastWave Medical announced today that it received a fourth utility patent to strengthen the IP foundation of its IVL platform. Minneapolis-based FastWave develops laser-based intravascular lithotripsy (IVL) technology for treating calcific artery disease. Its platform offers durable and fast energy delivery with enhanced sonic output to navigate complex arterial anatomy through a high-performing catheter. FastWave’s […]
Glucotrack expands CGM tech to spinal epidural space
Glucotrack (Nasdaq:GCTK) announced today that it plans to expand its glucose monitoring technology to measure glucose in the epidural space. Rutherford, New Jersey-based Glucotrack said CGM taking readings in the spinal epidural space could integrate with existing treatments for painful diabetic neuropathy (PDN). Specifically, Glucotrack sees spinal cord stimulation (SCS) technology as a potential integration […]
FDA approves XStim spine fusion stimulator
Xstim announced today that it received premarket approval from the FDA for its Xstim spine fusion stimulator device. Irving, Texas-based Xstim designed its capacitively coupled device to emit a low-energy signal. This, in turn, promotes bone healing following spinal fusion surgery. The company plans to make the device commercially available in the second quarter of […]
Johnson & Johnson EPS beats The Street in Q1, ups sales guidance
Johnson & Johnson shares dipped slightly today, even as first-quarter earnings came in ahead of the consensus forecast. Shares of JNJ fell 1% to $145.16 apiece by mid-day trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. The New Brunswick, New Jersey-based medtech giant […]
Olympus earns coverage win for iTind procedure
Olympus today announced positive changes to commercial payer policies covering patients who could benefit from its iTind procedure. iTind treats symptoms of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), or enlarged prostate. Aetna updated its Clinical Policy Bulletin 0079 for Benign Prostatic Hyperplasia to include the iTind procedure as medically necessary […]
IceCure submits final breast cancer cryoablation data to FDA
IceCure Medical (Nasdaq:ICCM) announced today that it submitted final data to the FDA requesting marketing authorization for its ProSense system. Caesarea, Israel-based IceCure designed ProSense to deliver cryoablation that treats breast cancer in a 20-40-minute outpatient procedure. It seeks FDA authorization for treating patients with early-stage T1 invasive breast cancer with cryoablation and adjuvant hormone […]